Prodotti competitors / Area HIV 8 ottobre 2021 ViiV Submits sNDA for Triumeq (abacavir/dolutegravir/lamivudine) Dispersible Tablet for Children Living with HIV
Prodotti competitors / Area HIV 4 ottobre 2021 TANGO: Three-year Dovato study shows non-inferiority to TAF-based regimens
